Cell therapy manufacturing, powered by partnership.
We work with leaders across the industry to bring proven instruments, technologies, and manufacturing expertise together into one coordinated platform. Together with our partners, we are creating the infrastructure needed to make cell therapies commercially viable at global scale.
“Automation is essential for the growing demand for cell therapies. We are so proud to partner with Cellular Origins. Thermo Fisher Scientific believes the most effective way to innovate is to collaborate across the sector with cutting-edge technologies, products and ideas like those from Cellular Origins to address pain points and bottlenecks.”
.
"Fresenius Kabi chose to collaborate with Cellular Origins because Cellular Origins has this unique technology, this unique platform with their Constellation® system, which is designed to enable scalable, closed and digitally integrated cell and gene therapy manufacturing. This is advantageous for cell therapy developers specifically because they can integrate their existing, modular cell processing systems into the Constellation system."
“We’re really excited for what Cellular Origins is doing and what the Constellation promise is. The future is very exciting. Can we manufacture these at a cost that makes sense for the healthcare systems around the globe? That is exactly what these partnerships aim to do. Drive the cost of goods down as these become frontline treatments.”
.
“We’re delighted to partner with Cellular Origins here at the Cell and Gene Therapy Catapult to deploy the Constellation system in our new digital and automation testbeds. The flexibility of the Constellation system, the ability to integrate with existing and future technology, without disrupting fluid paths, to give a rapid scale-appropriate methodology for Developers to get to industrialisation I think is absolutely compelling.”
Working with the best, across the board.
The Constellation® platform is designed to protect cell therapy developers’ biology and validated processes as manufacturing scales. This means integrating the trusted bioprocessing tools and technologies they already use into a coordinated, automated system.
Our partners understand their instruments and processes. We understand automation, manufacturing flow and scale-up. Together, we work side-by-side to ensure automation preserves the biology, workflows and performance therapy developers already trust.
Co-development
We work with bioprocessing instrument providers to robotically integrate their instruments and consumables into the Constellation® ecosystem with minimal modification to validated systems, preserving process familiarity and comparability.
Co-supply
We coordinate with suppliers to install and support systems. Instruments are supplied through Cellular Origins, while consumables continue to come directly from the original manufacturer, preserving established supply chains, product consistency and GMP confidence.
Co-marketing
We collaborate with partners to share knowledge and expertise that drives awareness and progress across our sector.
“Automation is essential for the growing demand for cell therapies. We are so proud to partner with Cellular Origins. Thermo Fisher Scientific believes the most effective way to innovate is to collaborate across the sector with cutting-edge technologies, products and ideas like those from Cellular Origins to address pain points and bottlenecks.”
- Mary Kay Bates, Sr. Global Applications Scientist, Thermo Fisher Scientific
"Fresenius Kabi chose to collaborate with Cellular Origins because Cellular Origins has this unique technology, this unique platform with their Constellation® system, which is designed to enable scalable, closed and digitally integrated cell and gene therapy manufacturing. This is advantageous for cell therapy developers specifically because they can integrate their existing, modular cell processing systems into the Constellation system."
- Avnie Kadakia, Sr. Director Global Commercial Sales & Marketing (C&CT Technologies), Fresenius Kabi
Protect your biological performance and validated workflows.
Automation designed to preserve the process you've spent years perfecting.
Minimise comparability risk.
Scale-up manufacturing with no unnecessary process change.
Preserve your technology choices.
Bioprocessing technologies will continue to advance. We make sure you can advance with them.
Why collaboration matters.
Successful cell therapy manufacturing automation depends on preserving the workflows, instruments and consumables developers already trust. Through deep partnerships with leading technology providers, Constellation helps developers scale manufacturing while minimising comparability risk and unnecessary process change.
Protect your biological performance and validated workflows.
Automation designed to preserve the process you've spent years perfecting.
Minimise comparability risk.
Scale-up manufacturing with no unnecessary process change.
Preserve your technology choices.
Bioprocessing technologies will continue to advance. We make sure you can advance with them.
“We’re really excited for what Cellular Origins is doing and what the Constellation promise is. The future is very exciting. Can we manufacture these at a cost that makes sense for the healthcare systems around the globe? That is exactly what these partnerships aim to do. Drive the cost of goods down as these become frontline treatments.”
- Josh Ludwig, Global Director; Commercial Operations, ScaleReady
“We’re delighted to partner with Cellular Origins here at the Cell and Gene Therapy Catapult to deploy the Constellation system in our new digital and automation testbeds. The flexibility of the Constellation system, the ability to integrate with existing and future technology, without disrupting fluid paths, to give a rapid scale-appropriate methodology for Developers to get to industrialisation I think is absolutely compelling.”
- Stephen Ward, Chief Technology Officer, Cell and Gene Therapy Catapult
How we work with Fresenius Kabi.
"Our collaboration is amazing. There's no need for the bureaucracy in our relationship. We just get down to it and we're executing on these milestones together."
- Alaina Schlinker, Director, Global Field Application Support, Fresenius Kabi
Partner news
Cellular Origins to collaborate with Immatics on cell therapy manufacturing automation
May 2026
Constellation® roboticises Fresenius Kabi's Cue
Jan 2026
Constellation® roboticises Cytiva's Sefia Select
Mar 2026
Cellular Origins announces collaboration with Thermo Fisher Scientific
Jun 2025